⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL524461 | 1.00 | — | — | |
| SCHEMBL16672118 | 0.71 | — | — | |
| SCHEMBL216115 | 0.63 | — | — | |
| SCHEMBL3504454 | 0.63 | — | — | |
| SCHEMBL216116 | 0.63 | — | — | |
| SCHEMBL8057875 | 0.59 | — | — | |
| SCHEMBL9068679 | 0.58 | — | — | |
| SCHEMBL19126061 | 0.54 | — | — | |
| SCHEMBL2187467 | 0.54 | — | — | |
| SCHEMBL580372 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025022284-A1 | METHOD FOR IN-CAPILLARY DISSOCIATION AND ANALYSIS OF MASS SPECTRAL DATA | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2025-01-30 | — | — | WO | disclosed |
| US-20240082414-A1 | HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES | ELI LILLY AND COMPANY | 2024-03-14 | — | — | US | disclosed |
| EP-4151648-A1 | BACULOVIRUS EXPRESSION SYSTEM | Centre National de la Recherche Scientifique (CNRS) (FR) | 2023-03-22 | — | — | EP | disclosed |
| EP-3494127-B1 | BACULOVIRUS EXPRESSION SYSTEM | CENTRE NAT RECH SCIENT (FR) | 2022-09-28 | — | — | EP | disclosed |
| US-10795058-B2 | Silicone-based hydrophilic copolymer and hydrogel compositions comprising the same | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-10-06 | — | — | US | disclosed |
| EP-3494127-A1 | BACULOVIRUS EXPRESSION SYSTEM | Centre National De La Recherche Scientifique (FR) | 2019-06-12 | — | — | EP | disclosed |
| US-10221271-B2 | Polymer/copper combination for targeted cancer therapy | UNIVERSITY OF SOUTH CAROLINA (US) | 2019-03-05 | — | — | US | disclosed |
| US-20180120480-A1 | SILICONE-BASED HYDROPHILIC COPOLYMER AND HYDROGEL COMPOSITIONS COMPRISING THE SAME | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-05-03 | — | — | US | disclosed |
| US-20180037687-A1 | Polymer/Copper Combination for Targeted Cancer Therapy | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-08 | — | — | US | disclosed |
| WO-2018024998-A1 | BACULOVIRUS EXPRESSION SYSTEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-02-08 | — | — | WO | disclosed |
| US-5202256-A | DNA segment encoding mussel protein linked to promoter and transcription initiation signals | ENZON LABS, INC. (US) | 1993-04-13 | — | — | US | disclosed |
| WO-1993000107-A1 | THERAPEUTIC FRAGMENTS OF VON WILLEBRAND FACTOR | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| US-5049504-A | Protein | GENEX CORPORATION (US) | 1991-09-17 | — | — | US | disclosed |
| EP-0332660-A4 | BIOADHESIVES | — | 1990-12-05 | — | — | EP | disclosed |
| EP-0380633-A4 | ARTERIOSCLEROSIS PROGNOSTICATION PROCEDURE AND THERAPEUTIC METHOD | — | 1990-12-05 | — | — | EP | disclosed |
| EP-0380633-A1 | ARTERIOSCLEROSIS PROGNOSTICATION PROCEDURE AND THERAPEUTIC METHOD | EAST TENNESSEE STATE UNIVERSITY (US) | 1990-08-08 | — | — | EP | disclosed |
| WO-1990000365-A1 | ARTERIOSCLEROSIS PROGNOSTICATION PROCEDURE AND THERAPEUTIC METHOD | EAST TENNESSEE STATE UNIVERSITY (US) | 1990-01-25 | — | — | WO | disclosed |
| EP-0332660-A1 | BIOADHESIVES | Enzon Labs Inc. (US) | 1989-09-20 | — | — | EP | disclosed |
| EP-0287206-A1 | Vaccine against pasteurella | BTG INTERNATIONAL LIMITED (GB) | 1988-10-19 | — | — | EP | disclosed |
| WO-1988003953-A1 | BIOADHESIVES | GENEX CORPORATION (US) | 1988-06-02 | — | — | WO | disclosed |